Company / Income Tax
Pacira BioSciences, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$9.8M
FY2025
5-year range
-$2.6M / $36.5M
FY2021-FY2025
Trend
-73.0%
vs FY2024
Sector context
#47 of 204
Health Care
What the data says
Pacira BioSciences, Inc.'s income tax of $10M is higher than 77% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$3M in FY2022 to $36M in FY2024.
Based on SEC 10-K filings.
$10M in FY2025 with a 5-year CAGR of +192.4%. Top quartile in the Health Care sector.
Improved from $20M to $10M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +192.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 204This company $9.8M Sector average $118.7M
▼
-91.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +192.4%, indicating consistent growth.
- In FY2025, income tax decreased 73.0% year-over-year.
- Ranks #47 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.8M | -73.0% |
| FY2024 | $36.5M | +84.6% |
| FY2023 | $19.7M | +857.4% |
| FY2022 | -$2.6M | -1072.8% |
| FY2021 | $268.0K | +482.6% |
| FY2020 | $46.0K | -67.1% |
| FY2019 | $140.0K | +33.3% |
| FY2018 | $105.0K | -60.2% |
| FY2017 | $264.0K | +151.4% |
| FY2016 | $105.0K | -60.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026